$RLFTF (related) NeuroRx NeuroRxPharma · 8h Listen to our 3/29 investor call on ZYESAMI™ demonstrating significant benefit in critical #COVID19 survival and meeting the primary endpoint of phase 2b/3 clinical trial:
https://bit.ly/3dt7MOP
aviptadil ZYESAMI